Athos Therapeutics Announces The Completion Of Its Oversubscribed Series A Financing
PRIVATENov 15, 2021
Round Type
Series A
TorranceBiotechnologyHealthcareHealth CareScience And Engineering
Description
Athos Therapeutics, Inc., a late preclinical stage biotechnology company pioneering the development of first-in-class precision therapeutics for patients with autoimmune diseases and cancer, announced today the completion of an oversubscribed $15MM Series A financing.
Who to call at Athos Therapeutics, Inc., and when
A new round usually means Athos Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Athos Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Athos Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Athos Therapeutics, Inc.. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Athos Therapeutics, Inc.
Location
11301 OLYMPIC BLVD., SUITE 592
Torrance, California, United States
About
Athos Therapeutics Inc. is a late-stage preclinical biotech company developing small molecule therapeutics for immune-mediated diseases and cancer using artificial intelligence-generated innovative chemistry and computational platforms. The co-founders of Athos include one of the founders of Kite Pharma (acquired for $12B), the medicinal chemist behind two multi-billion-dollar FDA-approved drugs (Xtandi & Erleada), and the discoverer of the miR-124 drug target, currently in a Phase III IBD trial. Athos identifies novel drug targets (hubs) by integrating clinical and molecular datasets into the biological network of a disease (the disease interactome) and matches them to its small molecule computational chemistry platform. ATH-63, the Company's lead drug compound, is moving into a Phase Ia human clinical early in 2022. The Athos pipeline includes small molecule approaches for various autoimmune disease and cancer.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Athos Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
TorranceBiotechnologyHealthcareHealth CareScience And Engineering